Prognostic value of cell-free DNA in cerebrospinal fluid from lung cancer patients with brain metastases during radiotherapy

BACKGROUND: During the last decades, radiotherapy (RT) for non-small cell lung cancer (NSCLC) with brain metastases (BM) has been developed. However, the lack of predictive biomarkers for therapeutic responses has limited the precision treatment in NSCLC-BM. PATIENTS AND METHODS: In order to find th...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Simiao, Hao, Yuying, Cai, Linbo, Duan, Xiaotong, Wang, Lijuan, Zhou, Aidong, Zhu, Xiaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007729/
https://www.ncbi.nlm.nih.gov/pubmed/36906568
http://dx.doi.org/10.1186/s13014-023-02239-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007729/
https://www.ncbi.nlm.nih.gov/pubmed/36906568
http://dx.doi.org/10.1186/s13014-023-02239-y

Ejemplares similares